Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-01-13 00:00:00 ET · period of report 2025-01-10 · accession 0000950170-25-004580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2025-01-10 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $1.22 | +11.4K | 35.9K | +47% | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depository Shares representing Ordinary Shares | 2025-01-10 | A | A | 11,439 | $1.22 | 35,860 | D | — | — | (F1) Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F2) On January 10, 2025, the Reporting Person acquired 11,439 ADS at purchase price of $1.22 per ADS. |